ASweetLife Team, Author at ASweetLife

Extreme Obesity Affecting More Children

According to a Kaiser Permanente study of 710,949 children and teens, extreme obesity is affecting more children at younger ages, with 12 percent of black teenage girls, and 11.2 percent of Hispanic teenage boys now classified as extremely obese. In the study researchers used measured height and weight in electronic health records to conduct a cross-sectional study of 710,949 children...

Takeda Withdraws European Marketing Authorization Application For Type 2 Diabetes Drug

Takeda Pharmaceutical Company Limited announced today that its wholly-owned subsidiary Takeda Global Research & Development Centre (Europe) Ltd. withdrew a European Marketing Authorization Application (MAA) for Competac...

Senator Asks Drug Companies to Explain High Prices

Senator Herb Kohl (D), chair of the Special Committee on Aging, sent letters to AstraZeneca, GlaxoSmithKline, Eli Lilly, Novartis, Pfizer, and Sanofi-Aventis asking them to explain why Americans on average pay twice as much as people in other industrialized countries for prescription drugs...

Medtronic Receives FDA Approval for Diabetes Management System

Medtronic, Inc. announced it has received U.S. Food and Drug Administration (FDA) approval for the MiniMed Paradigm® REAL-Time Revel™ System, an integrated diabetes management system which combines insulin pump therapy, continuous glucose monitoring (CGM) and diabetes therapy management software...

New Type 2 Diabetes Drug May Be On The Way

An Ohio State University study found that an experimental oral drug lowers blood sugar levels and inflammation in mice with type 2 diabetes, suggesting that the medication could someday be used to treat humans with type 2 diabetes. The drug consists of a synthetic molecule that stops the biological activity of a protein called macrophage...

European Artificial Pancreas On The Way

According to a JDRF press release, a consortium of academic and industrial partners has announced a collaboration called AP@home that aims to develop an artificial pancreas which would allow automated glucose control for people with insulin treated diabetes. In the first phase of the AP@home project, currently available AP algorithms will be tested with CGM (continuous glucose monitoring) systems and insulin pumps...

Amylin, Lilly and Alkermes Receive FDA Complete Response Letter for Exenatide Once Weekly

Amylin Pharmaceuticals Inc., Eli Lilly and Company and Alkermes, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for BYDUREON(TM). In the complete response letter there are no requests for new pre-clinical or clinical trials. Requests raised in the letter primarily relate to the finalization of the product labeling with accompanying Risk Evaluation and Mitigation Strategy (REMS) and clarification of existing manufacturing processes. The companies view this response as a positive step forward...

FDA Requests Additional Information From Mannkind Corp. Regarding AFREZZA

MannKind Corporation announced that it has received a Complete Response letter from the U.S. Food & Drug Administration (FDA) regarding the New Drug Application (NDA) for AFREZZA(TM) Inhalation Powder for the treatment of adult patients with type 1 and type 2 diabetes...

Plan Ahead: Make a Shopping List

Make a shopping list before you go to the supermarket and then buy only the items you've written down. If you allow yourself to roam the aisles in a store, you're much more likely to buy food products you don't need and that aren't good for you. Entering the supermarket with a plan will save you time, money, and help you keep your blood sugar levels in check.

Diamyd US Phase III study of Type 1 Drug Well on the Way

Diamyd Medical announced that 100 patients are now enrolled in the company's US Phase III study called DiaPrevent at 33 diabetes centers throughout the USA and more sites are to be added. The study will include 320 children and adolescents between 10 and 20 years of age, recently diagnosed with type 1 diabetes....